Gilead Sciences

-$1.73 (-2.56%) Today

+$0.03 (+0.05%) As of 11:21 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GILD and other ETFs, options, and stocks.

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.

CEO

Daniel P. O'Day

Employees

13,600

Headquarters

Foster City, California

Founded

1987

GILD Key Statistics

Market Cap

82.63B

Price-Earnings Ratio

16.51

Dividend Yield

4.15

Average Volume

6.07M

High Today

$67.59

Low Today

$65.78

Open Price

$67.52

Volume

7.52M

52 Week High

$73.34

52 Week Low

$56.56

GILD News

MarketWatchOct 15

Gilead's Sacituzumab Govitecan Gets Positive CHMP Opinion in Breast Cancer

By Michael Dabaie Gilead Sciences Inc. said the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion for

Simply Wall StOct 14

What Kind Of Shareholders Own Gilead Sciences, Inc.?

A look at the shareholders of Gilead Sciences, Inc. (NASDAQ:GILD) can tell us which group is most powerful. Large companies usually have institutions as shareho

Analyst Ratings

52%

of 25 ratings

Buy

44%

Hold

52%

Sell

GILD Earnings

$0.00

$0.73

$1.46

$2.19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Available Oct 28, After Hours